ICCM
Icecure MedicalNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$26.79M
P/E Ratio
—
EPS
$-0.24
Beta
2.52
52W High
$1.40
52W Low
$0.28
50-Day MA
$0.57
200-Day MA
$0.79
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Icecure Medical
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.
Fundamentals
| Revenue (TTM) | $3.38M |
| Gross Profit (TTM) | $1.23M |
| EBITDA | $-14.80M |
| Operating Margin | -329.60% |
| Return on Equity | -188.80% |
| Return on Assets | -71.30% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.12 |
| Price-to-Book | 2.69 |
| Price-to-Sales (TTM) | 7.93 |
| EV/Revenue | 4.639 |
| EV/EBITDA | -2.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 46.20% |
| Shares Outstanding | $81.18M |
| Float | $15.87M |
| % Insiders | 46.66% |
| % Institutions | 0.65% |
Analyst Ratings
Consensus ($2.73 target)
1
Strong Buy1
BuyData last updated: 4/8/2026